AstraZeneca PLC


  • *$106 bln Pfizer bid stirs up political storm on job fears. LONDON, May 11- How British is AstraZeneca? With a French chief executive, Swedish chairman, 40 percent of its sales in the United States and 87 percent of its staff overseas, the answer is not simple.

  • *CEO says UK science a key attraction of AstraZeneca deal. LONDON, May 10- U.S. drugmaker Pfizer fought back on Saturday against criticism that its planned takeover of rival AstraZeneca would damage Britain's science base by saying strong UK research was a key reason for the deal.

  • LONDON, May 10- Britain is ready for "hard negotiation" to ensure Pfizer sticks to specific promises on jobs and science under the U.S. drugmaker's proposed takeover of AstraZeneca, its finance minister said. "I think it would be extraordinary not to engage with AstraZeneca or Pfizer," George Osborne told BBC radio on Saturday.

  • US politicians step up scrutiny of Pfizer bid Saturday, 10 May 2014 | 5:50 AM ET

    Pfizer's $106 billion takeover approach for AstraZeneca is facing mounting scrutiny as senior U.S. politicians weigh in.

  • BUSINESS-NEWS-SCHEDULE AT 1530 GMT / 11:30 AM ET Friday, 9 May 2014 | 11:35 AM ET

    Wal-Mart should face lawsuit over alleged Mexico bribery- U.S. judge. Wal-Mart Stores Inc should face a U.S. lawsuit accusing it of defrauding shareholders by concealing suspected corruption at its Mexico operations, even after learning that a damaging media report detailing alleged bribery was being prepared, a federal judge says.

  • Publicis CEO: Merger off as 'equality impossible' Friday, 9 May 2014 | 11:27 AM ET
    Publicis CEO Maurice Levy stands on the the floor of the New York Stock Exchange a day after announcing that Omnicom Group and Publicis Groupe will merge to form the world's largest advertising holding company on July 29, 2013 in New York City.

    Publicis CEO Maurice Levy has told CNBC that the decision to call off a $35 billion merger with U.S.-based Omnicom was "an issue of principle."

  • 3 big reasons to buy stocks now: Hedge fund pro Friday, 9 May 2014 | 9:39 AM ET
    Traders on the floor of the New York Stock Exchange.

    There are a lot of tailwinds for the stock market right now, hedge fund manager Dan Arbess tells CNBC.

  • U.S. stock index futures pointed to a lower open on Wall Street on Friday, ahead of first quarter results from Liberty Interactive and Ralph Lauren.

  • LONDON, May 9- U.S. drugmaker Pfizer is under fire on both sides of the Atlantic as it weighs its next move to buy British rival AstraZeneca, which could be a sweetened offer next week.

  • LONDON, May 9- U.S. drugmaker Pfizer, battling to buy British rival AstraZeneca, has struck a deal with leading British universities to hunt for new medicines to treat rare diseases.

  • LONDON, May 9- The British government needs to be confident that any commitments made by Pfizer in a proposed takeover of AstraZeneca are binding, British Deputy Prime Minister Nick Clegg said on Friday.

  • Pfizer Chief Executive Ian Read has already given a five-year commitment to complete AstraZeneca's new research centre in Cambridge, retain a factory in Macclesfield, and put a fifth of its research staff in Britain if the deal goes ahead.

  • Pfizer/AstraZeneca: The numbers you need to watch Friday, 9 May 2014 | 4:47 AM ET

    Pfizer has been rebuffed more often than a particularly unlucky suitor in a romance novel by coy AstraZeneca.

  • Pfizer's attempt to escape the United States corporate tax rate has set off a flurry of activity within other big companies across the country, the New York Times reports.

  • May 8- The governors of Maryland and Delaware on Thursday sent a letter to Pfizer Inc Chief Executive Officer Ian Read "expressing deep concerns" about the pharmaceutical company's bid to acquire London- based AstraZeneca Plc.

  • Democratic Senator Carl Levin on Thursday said he plans to introduce legislation soon to prevent corporate inversions, an increasingly-popular transaction that involves U.S. companies reincorporating overseas to avoid U.S. taxes.

  • LONDON, May 8- The European Commission would probably block any attempt by the British government to intervene in Pfizer's proposed takeover of AstraZeneca as Brussels itself would rule on a deal of that size, competition lawyers say. AstraZeneca has rejected the $106 billion bid to create the world's largest pharmaceuticals business.

  • Early movers: AZN, TM, TSLA, RIG & more Thursday, 8 May 2014 | 7:38 AM ET
    Traders work the floor of the New York Stock Exchange on the evening of January 23, 2014 in New York City.

    Some of the names on the move ahead of the open.

  • *AstraZeneca meeting shareholders to canvass views. LONDON, May 8- AstraZeneca shares gained 2 percent on Thursday on speculation that U.S. drugmaker Pfizer was about to return with a higher bid worth more than 53 pounds a share, traders said.

  • LONDON, May 8- AstraZeneca shares gained 2 percent in early trading on Thursday on speculation that U.S. drugmaker Pfizer was about to return with a higher bid worth more than 53 pounds a share, traders said.